Jessup joined Aptium Oncology in April 1997 as its General Counsel. He was named chief executive officer and president of the company in July 1999. Prior to joining the company, Jessup spent the early years of his career as a solicitor in private practice with Cameron McKenna in London, before joining Imperial Chemical Industries PLC (ICI), where he served as senior solicitor. He also served as senior counsel for ICI Americas, Inc. from 1988-1990. Following AstraZeneca's separation from ICI in 1993, Jessup was appointed a dual role as deputy solicitor for the Zeneca Group and member of its International Agrochemicals Business Team. He earned his master's degree in law from Queens' College, Cambridge, England.

Mr. Rogers has been with Aptium Oncology since 1995, serving as Chief Financial Officer since 1997. Mr. Rogers spent the previous 17 years with Zeneca where he had responsibilities ranging from finance to territorial management to corporate strategy. Mr. Rogers received his MA in Metallurgy & Science of Materials from St. Edmond Hall, Oxford. He is an FCA and trained with KPMG.

Formerly Vice President and Executive Director of the Cedars-Sinai Outpatient Cancer Center The Samuel Oschin Comprehensive Cancer Institute, Paul O'Dea now holds the title of Chief Operating Officer at Aptium Oncology. Prior to his 20-year career with Aptium, O'Dea held pharmacy positions with several health care institutions, including the University of California, Los Angeles (UCLA). He earned his Bachelor of Science in Pharmacy from the University of Connecticut in 1969. O'Dea is a member of numerous professional organizations, including the Health Care Executives of Southern California and the American College of Healthcare Executives, the Association of Cancer Executives, and the Association of Community Cancer Centers.

Stephen Bordelon is Executive Vice President of Business Development & Consulting at Aptium Oncology, where his responsibilities include developing and executing new business relationships for the Company and providing senior consulting services to clients. Bordelon held field operational finance positions for his first five years with the Company, which he joined in 1992. Prior to joining the Company, he held a regional financial position with pharmacy corporation of america and a controllership position for a subsidiary of Foote, Cone & Belding. A graduate of Louisiana State University, Bordelon practiced as a Certified Public Accountant for five years in Baton Rouge, Louisiana.

As Chief Information Officer, Wes supports staff and enhances patient care at the cancer centers by providing better information, and delivering business value to client hospitals through customized IT solutions. Scruggs joined Aptium Oncology in 1997 in time to tackle the Y2K and process re-engineering job. By April 1999, all infrastructure was upgraded to provide stable and cost effective platforms for all administrative, clinical and business office operations. Promoted from Vice President of Information Technology to CIO in 1999, Scruggs has developed a highly skilled IT department and centralized support organization that recently helped develop an oncology-specific EMR. Wes recently earned CHCIO status (Certified Healthcare CIO) from CHIME and is a HIMSS member. An active member of healthcare CIO forums and organizations, Scruggs has presented on EMR selection and implementation. Prior to Aptium, he was Vice President of Corporate Systems at Sony Pictures Entertainment and Director of IT Operations for Health Net. Scruggs earned his MBA from Pepperdine University.

Victoria B. Carrington has been with Aptium Oncology since November 1999. She advises the company regarding a wide variety of regulatory, commercial and operational issues. Prior to joining the company, Carrington was an associate in the Los Angeles, California office of Miller & Holguin and the Norfolk, Virginia office of Kaufman & Canoles. Carrington received her J.D. cum laude from the University of Richmond. She received her bachelor's degree from the University of Virginia.

A graduate of Hahnemann University Medical School in Philadelphia, Dr. Berson completed his residency in Radiation Oncology at the University of California, San Francisco. Dr. Berson serves as Aptium's Corporate Radiation Oncology Director for the Eastern Region. In this role, he provides clinical oversight and leadership for radiation oncology services throughout the Aptium Network. Dr. Berson is an attending physician at St. Vincent's Comprehensive Cancer Center and New York Eye & Ear Infirmary. He adds to his long list of academic appointments and educational activities his current role as Professor of Clinical Radiation Medicine at the New York Medical College. Dr. Berson has authored numerous articles for scientific publications and has lectured extensively on radiation oncology, as well as presented CME Courses at various symposia and conferences.

As Vice President of Business Development & Consulting at Aptium Oncology, Michele Bollinger's responsibilities include developing new business relationships, leading consulting projects for clients, and managing the Company's corporate marketing and public relations efforts. Prior to joining the Company In 1994, Bollinger held positions with the Liver Transplant Program at UCLA Medical Center and with the National Health Service in London. Bollinger received an MBA with Honors from the University of Southern California.

Arthur Doi serves as Director of Financial Analysis and is responsible for financial analysis of new business opportunities. Doi joined Aptium Oncology in October 2001. He was previously with Unimed Management Company, a physician practice management company, for 10 years, holding various positions in the finance department, including Director of Finance. Doi received his bachelor of Science in Accounting from Loyola Marymount University and is a Certified Public Accountant.

Richard Emery began his career with Aptium Oncology in 1996, and was appointed Executive Director of Trinitas Comprehensive Cancer Center in 2005. Previously, Emery served as Administrative Director of Radiation Services for Aptium Oncology. He also served as Chief Physicist for St. Vincent's Comprehensive Cancer Center In Manhattan, where he was responsible for the technical and operational direction of both radiation oncology and diagnostic radiology. Emery received his MBA from the Stern School of Business at New York University.

As VP of Medical Affairs for Aptium Oncology, Myra Fouts works with the Business Development Team to help hospitals and physicians develop cancer centers that are designed to enhance patient care and workflow. Her specific responsibilities include space planning, staffing plans and clinical program design that meet the needs of the hospital and the community. During the development process, she works with clients and architects to develop the space design that best meets clinical program needs and provides a patient-centered, operationally efficient approach. Fouts presents nationally on the topic of cancer center design. Since 1992, Myra has held a variety of clinical and administrative roles within Aptium Oncology and Cedars Sinai Outpatient Cancer Center. She received her Masters of Nursing Administration from the University of Missouri and is credentialed in oncology and advanced nursing administration.

As Vice President of Pharmacy Services, William Guss provides guidance and leadership on pharmacy-related matters, direction and oversight on drug purchasing and 340B Programs, and consultation on operations and new business development. He also provides compliance oversight to navigate an increasingly complex regulatory environment. Guss joined Aptium Oncology in May 1992 to help create and manage an Aptium Subsidiary in home health care. Previously, he was a pharmacy specialist at UCLA Medical Center. He received his PharmD from the University of California at San Francisco and MBA from the Anderson Graduate School Of Management at UCLA.

As Chief Medical Officer of Aptium Oncology, Dr. John S. Macdonald establishes and maintains hospital and patient care quality and standards, as well as defines and ensures the effective delivery of oncology services. A graduate of Harvard Medical School and Trained in Medical Oncology at the National Cancer Institute, Macdonald is board-certified in internal medicine and medical oncology and served on the Oncology Subspecialty Committee of the American Board of Internal Medicine. This committee prepared the medical oncology subspecialty certification examination. An internationally recognized oncologist, Macdonald has authored over 300 articles, book chapters and abstracts. Previously, He served as Medical Director of the St. Vincent's Comprehensive Cancer Center in Manhattan. Currently, he serves as the Chairman of the Data and Safety Monitoring Committee (DMSC) of the Southwest Oncology Group and is a team leader of the Aptium Oncology GI Cancer Consortium.

Francine Moskowitz is responsible for development of new hospital consulting and management relationships. She holds a Master's Degree in Health Sciences from Hahnemann University Medical School in Philadelphia. Moskowitz operated a healthcare strategy consulting firm for more than 20 years, served as Executive Vice President and Chief Operating Officer for a national imaging services provider, and as a hospital executive in several management roles for a major hospital system and community hospitals. She is a Fellow of the American College of Healthcare Executives and is active in the American Hospital Association, the Association of Community Cancer Centers, the Association of Cancer Executives and other professional organizations.

As Director of Network Services for Aptium Oncology, David Pan is responsible for overseeing the Company's network infrastructure, IT Customer Support and nine data centers that include more than 250 servers. Pan earned his Bachelors Degree in Electrical and Electronic Engineering from California State University, Sacramento and has achieved numerous network certifications including Certified Netware Engineer (CNE), Microsoft Certified Systems Engineer (MCSE) and Cisco Certified Network Professional (CCNP). Prior to joining Aptium Oncology in 1998, Pan worked for NEC and AST as a Computer/Server Design Engineer.

Prior to joining Aptium Oncology in 1996, Michael Rhind worked at Price Waterhouse for seven years, Attaining the position of Tax Manager, where he provided consulting services to high net worth individuals and middle market companies. At Aptium, Rhind has held various positions, including Vice President, Taxation and Budgets, and Executive Director of Lynn Regional Cancer Center West. As Controller/ Vice President, Rhind provides guidance on financial forecasting and strategic planning, oversees revenue cycle operations, establishes accounting and reporting standards, and oversees the maintenance of financial controls for the organization. He Received his Bachelor's Degree in Economics and Business at UCLA and is a Certified Public Accountant. He is a member of several organizations, including the AICPA and Healthcare Financial Managers Association.